MAGEC3 and glioblastoma: Additionally, MAGE-C3 showed varying expression levels across different cancer types, with significantly higher expression in glioblastoma multiforme (GBM), Head and Neck Squamous Cell Carcinoma (HNSC), and Thyroid Carcinoma (THCA), as well as moderate levels in several other malignancies.